Sera Prognostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sera Prognostics, Inc. (SERA) on November 29, 2021. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Salt Lake City, Utah. Its Class A Common Stock trades on The Nasdaq Stock Market LLC under the symbol "SERA".
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance changes and director compensation arrangements.
Material Changes
On November 29, 2021, the Board of Directors appointed Sandra A.J. Lawrence as a Class II Director, effective immediately. Her term will expire at the Company's 2023 annual meeting of stockholders. No committee assignments have been determined at this time.
Compensation and Governance Details
- Stock Option Grant: Ms. Lawrence was granted a non-qualified stock option to purchase shares of common stock with a Grant Date fair value of $240,000. The exercise price equals the fair market value on the Grant Date.
- Vesting Schedule: The option vests in 36 substantially equal monthly installments, contingent on continued service.
- Cash Retainer: Ms. Lawrence is entitled to an annual cash retainer of $35,000, prorated for the portion of the year served.
- Indemnification: An indemnification agreement was executed, protecting Ms. Lawrence for expenses, judgments, fines, and settlements incurred in her service as a director to the maximum extent allowed under Delaware law.
Management Commentary and Risks
The Board cited Ms. Lawrence's extensive background in financial services, healthcare administration, and corporate governance as the rationale for her appointment. She brings experience from roles at Children's Mercy Hospital, Midwest Research Institute, and current board service at Evergy, Inc., American Shared Hospital Services, and Recology. The filing states there are no undisclosed arrangements or material interests involving Ms. Lawrence.
Investor Verification Checklist
- Verify the exact number of shares underlying the $240,000 stock option grant based on the closing stock price on November 29, 2021.
- Confirm the specific vesting commencement date and the first vesting milestone.
- Review the Company's Non-Employee Director Compensation Policy for details on prorated retainer calculations.
- Monitor future filings for Ms. Lawrence's committee assignments and any changes to the Board composition.